20 research outputs found

    Approaches to Assessing the Demand for Vocational Education

    Get PDF
    The article discusses the prospects for the development of regional systems of secondary vocational education (on the basis of basic general education) through the prism of assessing the demand for secondary vocational education and covering this level of education in the context of demography and competition from schools Keywords: secondary vocational education, demand for education, educational coverage, private educational organizations, regional education system

    The Need for Regional Labor Markets for Mid-Level Specialists and the Priorities of Graduates of Secondary Vocational Education in Employment Issues

    Get PDF
    The article considers the problems of imbalance of supply and demand in regional labor markets, as well as the role of career guidance in choosing a profession. The article discloses the main management decisions for regulating reception targets, taking into account labor market requirements. The authors give examples of calculating the imbalance of supply and demand in personnel in regional labor markets using the example of the region’s need for mid-level medical workers. The article considers the aspects of employment of graduates of professional educational organizations, including labor migration and international experience. As a result of the study, the authors identified and formulated the general laws of labor migration of graduates of professional educational organizations and solutions to reduce the outflow of labor resources from the region. Separately, the authors examined the employment of graduates of the SVE (secondary vocational education) system in Moscow and St. Petersburg. The article was completed within the framework of the topic of the State Task of the RANEPA N 11.5 β€œStudy of models for the transformation of regional systems of secondary vocational education and their need for resource support” for 2021

    Science at Universities – the Development Driver or Privilege of the Selected Ones

    Get PDF
    The research article considers an influence of university research funding on the development of different kind of universities. During last 10–15 years a lot of strategic documents regarding development of science and higher education mention an importance of intensive grow on research in universities. They should transform to research centers instead of just education facilities, lead a scientific field in Russia. Presumably such additions in science management practices as new evaluation, stimulation and efficiency improvement instruments and mechanisms will increase an influence of R&D departments on whole university development. The main purpose of current article is to analyze trends in shifts of research funding indicators for universities of different profiles and for higher education sector in general; to compare research funding volume with public indicators of university development; to evaluate the impact of research in higher education to higher institution development indicators. During the study our group has analyzed connections between research funding indicators and individual R&D efficiency indicators at universities. The analysis is based on statistics from Federal State Statistics Service, and annual monitoring of university activities for the period 2014–2020, from Ministry of Education and Science of Russia. The result of the study shows an insignificant effect of university research funding volume to university development indicators; high government participance in higher institutions research development; significant irregularity and historical inertia in reorganization of universities to large scientific and education centers.Данная ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Ρ‚Π΅Π»ΡŒΡΠΊΠ°Ρ ΡΡ‚Π°Ρ‚ΡŒΡ посвящСна ΠΏΡ€ΠΎΠ±Π»Π΅ΠΌΠ΅ влияния финансирования вузовской Π½Π°ΡƒΠΊΠΈ Π½Π° Ρ€Π°Π·Π²ΠΈΡ‚ΠΈΠ΅ Π²ΡƒΠ·ΠΎΠ² Ρ€Π°Π·Π½ΠΎΠ³ΠΎ профиля. Π’ послСдниС 10–15 Π»Π΅Ρ‚ Π² стратСгичСских Π΄ΠΎΠΊΡƒΠΌΠ΅Π½Ρ‚Π°Ρ… ΠΏΠΎ вопросам развития Π½Π°ΡƒΠΊΠΈ ΠΈ Π²Ρ‹ΡΡˆΠ΅Π³ΠΎ образования, Π½Π°ΠΏΡ€ΠΈΠΌΠ΅Ρ€, Π² ГосударствСнной ΠΏΡ€ΠΎΠ³Ρ€Π°ΠΌΠΌΠ΅ «Научно-тСхнологичСскоС Ρ€Π°Π·Π²ΠΈΡ‚ΠΈΠ΅ Российской Π€Π΅Π΄Π΅Ρ€Π°Ρ†ΠΈΠΈΒ», ΠΠ°Ρ†ΠΈΠΎΠ½Π°Π»ΡŒΠ½ΠΎΠΌ ΠΏΡ€ΠΎΠ΅ΠΊΡ‚Π΅ «Наука ΠΈ унивСрситСты», ΠŸΡ€ΠΎΠ³Ρ€Π°ΠΌΠΌΠ΅ стратСгичСского акадСмичСского лидСрства ΠΈ Ρ‚. ΠΏ., Π² явном ΠΈ нСявном Π²ΠΈΠ΄Π΅ формулируСтся Π·Π°Π΄Π°Ρ‡Π° интСнсивного развития Π½Π°ΡƒΡ‡Π½Ρ‹Ρ… исслСдований Π² Π²ΡƒΠ·Π°Ρ…, прСвращСния Π²ΡƒΠ·ΠΎΠ² ΠΈΠ· прСимущСствСнно ΠΎΠ±Ρ€Π°Π·ΠΎΠ²Π°Ρ‚Π΅Π»ΡŒΠ½Ρ‹Ρ… Π² Π½Π°ΡƒΡ‡Π½ΠΎ-ΠΎΠ±Ρ€Π°Π·ΠΎΠ²Π°Ρ‚Π΅Π»ΡŒΠ½Ρ‹Π΅ Ρ†Π΅Π½Ρ‚Ρ€Ρ‹, Π·Π°Π½ΠΈΠΌΠ°ΡŽΡ‰ΠΈΠ΅ Π»ΠΈΠ΄ΠΈΡ€ΡƒΡŽΡ‰ΠΈΠ΅ ΠΏΠΎΠ·ΠΈΡ†ΠΈΠΈ Π² систСмС Π½Π°ΡƒΡ‡Π½Ρ‹Ρ… исслСдований страны. ΠŸΡ€Π΅Π΄ΠΏΠΎΠ»Π°Π³Π°Π΅Ρ‚ΡΡ, Ρ‡Ρ‚ΠΎ Π²Π²ΠΎΠ΄ΠΈΠΌΡ‹Π΅ Π² ΠΏΡ€Π°ΠΊΡ‚ΠΈΠΊΡƒ управлСния Ρ€Π°Π·Π»ΠΈΡ‡Π½Ρ‹Π΅ инструмСнты ΠΈ ΠΌΠ΅Ρ…Π°Π½ΠΈΠ·ΠΌΡ‹ ΠΎΡ†Π΅Π½ΠΊΠΈ, стимулирования ΠΈ ΠΏΠΎΠ²Ρ‹ΡˆΠ΅Π½ΠΈΡ эффСктивности Π½Π°ΡƒΡ‡Π½Ρ‹Ρ… исслСдований Π±ΡƒΠ΄ΡƒΡ‚ ΡƒΡΠΈΠ»ΠΈΠ²Π°Ρ‚ΡŒ влияниС вузовской Π½Π°ΡƒΠΊΠΈ Π½Π° комплСксноС Ρ€Π°Π·Π²ΠΈΡ‚ΠΈΠ΅ Π²ΡƒΠ·ΠΎΠ². ЦСль настоящСй ΡΡ‚Π°Ρ‚ΡŒΠΈ – ΠΏΡ€ΠΎΠ°Π½Π°Π»ΠΈΠ·ΠΈΡ€ΠΎΠ²Π°Ρ‚ΡŒ Ρ‚Π΅Π½Π΄Π΅Π½Ρ†ΠΈΠΈ измСнСния ΠΏΠΎΠΊΠ°Π·Π°Ρ‚Π΅Π»Π΅ΠΉ финансирования Π½Π°ΡƒΡ‡Π½Ρ‹Ρ… исслСдований Π² Π²ΡƒΠ·Π°Ρ… Ρ€Π°Π·Π½Ρ‹Ρ… ΠΏΡ€ΠΎΡ„ΠΈΠ»Π΅ΠΉ ΠΈ Π² Ρ†Π΅Π»ΠΎΠΌ Π² сфСрС Π²Ρ‹ΡΡˆΠ΅Π³ΠΎ образования, ΡΠΎΠΏΠΎΡΡ‚Π°Π²ΠΈΡ‚ΡŒ ΠΎΠ±ΡŠΠ΅ΠΌΡ‹ финансирования вузовской Π½Π°ΡƒΠΊΠΈ с доступными Π΄Π°Π½Π½Ρ‹ΠΌΠΈ ΠΎ Ρ€Π°Π·Π»ΠΈΡ‡Π½Ρ‹Ρ… характСристиках развития Π²ΡƒΠ·ΠΎΠ² ΠΈ ΠΎΡ†Π΅Π½ΠΈΡ‚ΡŒ влияниС финансирования Π½Π°ΡƒΡ‡Π½Ρ‹Ρ… исслСдований Π² Π²Ρ‹ΡΡˆΠ΅ΠΉ школС Π½Π° ΠΏΠΎΠΊΠ°Π·Π°Ρ‚Π΅Π»ΠΈ развития Π²ΡƒΠ·ΠΎΠ². Π’ Ρ…ΠΎΠ΄Π΅ исслСдования Π°Π½Π°Π»ΠΈΠ·ΠΈΡ€ΠΎΠ²Π°Π»ΠΈΡΡŒ связи ΠΏΠΎΠΊΠ°Π·Π°Ρ‚Π΅Π»Π΅ΠΉ финансирования Π½Π°ΡƒΡ‡Π½Ρ‹Ρ… исслСдований Π² Π²ΡƒΠ·Π°Ρ… с ΠΎΡ‚Π΄Π΅Π»ΡŒΠ½Ρ‹ΠΌΠΈ показатСлями Ρ€Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚ΠΈΠ²Π½ΠΎΡΡ‚ΠΈ Π½Π°ΡƒΡ‡Π½Ρ‹Ρ… исслСдований ΠΈ развития Π²ΡƒΠ·ΠΎΠ². Для Π°Π½Π°Π»ΠΈΠ·Π° использовались статистичСскиС Π΄Π°Π½Π½Ρ‹Π΅ Ρ„Π΅Π΄Π΅Ρ€Π°Π»ΡŒΠ½ΠΎΠΉ слуТбы государствСнной статистики, свСдСния ΠΏΡ€ΠΎΠ²ΠΎΠ΄ΠΈΠΌΠΎΠ³ΠΎ ΠœΠΈΠ½ΠΎΠ±Ρ€Π½Π°ΡƒΠΊΠΈ России ΠΌΠΎΠ½ΠΈΡ‚ΠΎΡ€ΠΈΠ½Π³Π° Π΄Π΅ΡΡ‚Π΅Π»ΡŒΠ½ΠΎΡΡ‚ΠΈ Π²ΡƒΠ·ΠΎΠ² Π·Π° ΠΏΠ΅Ρ€ΠΈΠΎΠ΄ 2014–2020 Π³Π³. ИсслСдованиС ΠΏΠΎΠΊΠ°Π·Π°Π»ΠΎ Π½Π΅Π·Π½Π°Ρ‡ΠΈΡ‚Π΅Π»ΡŒΠ½ΠΎΠ΅ влияниС объСмов финансирования вузовской Π½Π°ΡƒΠΊΠΈ Π½Π° ΠΏΠΎΠΊΠ°Π·Π°Ρ‚Π΅Π»ΠΈ развития Π²ΡƒΠ·ΠΎΠ², Π·Π½Π°Ρ‡ΠΈΡ‚Π΅Π»ΡŒΠ½ΡƒΡŽ Ρ€ΠΎΠ»ΡŒ государства Π² Ρ€Π°Π·Π²ΠΈΡ‚ΠΈΠΈ Π½Π°ΡƒΡ‡Π½Ρ‹Ρ… исслСдований Π² Π²Ρ‹ΡΡˆΠ΅ΠΉ школС ΠΈ ΡΡƒΡ‰Π΅ΡΡ‚Π²Π΅Π½Π½ΡƒΡŽ Π½Π΅Ρ€Π°Π²Π½ΠΎΠΌΠ΅Ρ€Π½ΠΎΡΡ‚ΡŒ ΠΈ ΠΈΡΡ‚ΠΎΡ€ΠΈΡ‡Π΅ΡΠΊΡƒΡŽ ΠΈΠ½Π΅Ρ€Ρ†ΠΈΠΎΠ½Π½ΠΎΡΡ‚ΡŒ Π² становлСнии Π²ΡƒΠ·ΠΎΠ² ΠΊΠ°ΠΊ ΠΊΡ€ΡƒΠΏΠ½Ρ‹Ρ… Π½Π°ΡƒΡ‡Π½ΠΎ-ΠΎΠ±Ρ€Π°Π·ΠΎΠ²Π°Ρ‚Π΅Π»ΡŒΠ½Ρ‹Ρ… Ρ†Π΅Π½Ρ‚Ρ€ΠΎΠ²

    ΠŸΠ Π•Π”Π’ΠΠ Π˜Π’Π•Π›Π¬ΠΠ«Π• РЕЗУЛЬВАВЫ Π˜Π‘ΠŸΠžΠ›Π¬Π—ΠžΠ’ΠΠΠ˜Π― ЀВОРАЀУРА Π’ ΠšΠžΠœΠ‘Π˜ΠΠΠ¦Π˜Π˜ Π‘ Π˜Π Π˜ΠΠžΠ’Π•ΠšΠΠΠžΠœ И ΠžΠšΠ‘ΠΠ›Π˜ΠŸΠ›ΠΠ’Π˜ΠΠžΠœ Π£ ΠŸΠΠ¦Π˜Π•ΠΠ’ΠžΠ’ Π‘ Π ΠΠ‘ΠŸΠ ΠžΠ‘Π’Π ΠΠΠ•ΠΠΠ«Πœ ΠšΠžΠ›ΠžΠ Π•ΠšΠ’ΠΠ›Π¬ΠΠ«Πœ РАКОМ

    Get PDF
    Objective: to develop an effective, well-tolerated, convenient for outpatient care (without installing a subclavian catheter) three-component treatment regimen that includes ftorafur – an original oral fluoropyrimidine drug.Materials and methods. The study included 25 patients with disseminated colorectal cancer that have never received specific pharmacotherapy. We evaluated the efficacy and safety of a new first-line three-component treatment regimen with oxaliplatin + irinotecan + ftorafur. Patients in group 1 (n = 6) received this regimen for 3 weeks, whereas patients in group 2 (n = 19) received it for 2 weeks.Results. Only preliminary results of the study are currently available. Median time to progression and overall survival are not yet estimated. Three (50 %) patients from group 1 achieved partial regression of metastases; 3 patients from this group had long-term (β‰₯6 months) disease stabilization. Therapeutic effect (partial remission + long-term stabilization) was observed in all patients. Time without progression varied between 6 and 20 months. In group 2, therapeutic effect was estimated in 18 patients that received at least 2 courses of chemotherapy. Eight out of these 18 patients had partial response (2 of them underwent radical surgery); 8 patients had disease stabilization. Thus, 88.8 % of patients from group 2 responded to treatment. In the whole study population (both groups), response to treatment was achieved in 91 % of patients.Conclusion. Our preliminary results suggest that the combination of oxaliplatin, irinotecan and ftorafur is safe and has an acceptable toxicity profile; therefore, it can be used in weakened patients.ЦСль исслСдования – Ρ€Π°Π·Ρ€Π°Π±ΠΎΡ‚ΠΊΠ° ΡƒΠ΄ΠΎΠ±Π½ΠΎΠ³ΠΎ для Π°ΠΌΠ±ΡƒΠ»Π°Ρ‚ΠΎΡ€Π½ΠΎΠΉ ΠΏΡ€Π°ΠΊΡ‚ΠΈΠΊΠΈ (Π±Π΅Π· нСобходимости установки ΠΏΠΎΠ΄ΠΊΠ»ΡŽΡ‡ΠΈΡ‡Π½ΠΎΠ³ΠΎ ΠΏΠΎΡ€Ρ‚Π°), Ρ…ΠΎΡ€ΠΎΡˆΠΎ пСрСносимого ΠΈ эффСктивного Ρ‚Ρ€Π΅Ρ…ΠΊΠΎΠΌΠΏΠΎΠ½Π΅Π½Ρ‚Π½ΠΎΠ³ΠΎ Ρ€Π΅ΠΆΠΈΠΌΠ°, Π²ΠΊΠ»ΡŽΡ‡Π°ΡŽΡ‰Π΅Π³ΠΎ ΠΏΠ΅Ρ€ΠΎΡ€Π°Π»ΡŒΠ½Ρ‹ΠΉ ΠΎΡ€ΠΈΠ³ΠΈΠ½Π°Π»ΡŒΠ½Ρ‹ΠΉ ΠΏΡ€Π΅ΠΏΠ°Ρ€Π°Ρ‚ Ρ„Ρ‚ΠΎΡ€ΠΏΠΈΡ€ΠΈΠΌΠΈΠ΄ΠΈΠ½ΠΎΠ²ΠΎΠ³ΠΎ ряда Ρ„Ρ‚ΠΎΡ€Π°Ρ„ΡƒΡ€.ΠœΠ°Ρ‚Π΅Ρ€ΠΈΠ°Π»Ρ‹ ΠΈ ΠΌΠ΅Ρ‚ΠΎΠ΄Ρ‹. Π’ исслСдованиС Π±Ρ‹Π»ΠΈ Π²ΠΊΠ»ΡŽΡ‡Π΅Π½Ρ‹ 25 ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ² с распространСнным ΠΊΠΎΠ»ΠΎΡ€Π΅ΠΊΡ‚Π°Π»ΡŒΠ½Ρ‹ΠΌ Ρ€Π°ΠΊΠΎΠΌ, Π½Π΅ ΠΏΠΎΠ»ΡƒΡ‡Π°Π²ΡˆΠΈΡ… Ρ€Π°Π½Π΅Π΅ спСцифичСского лСкарствСнного лСчСния, Ρƒ ΠΊΠΎΡ‚ΠΎΡ€Ρ‹Ρ… Π² 1-ΠΉ Π»ΠΈΠ½ΠΈΠΈ лСчСния ΠΎΡ†Π΅Π½Π΅Π½Ρ‹ ΡΡ„Ρ„Π΅ΠΊΡ‚ΠΈΠ²Π½ΠΎΡΡ‚ΡŒ ΠΈ Π±Π΅Π·ΠΎΠΏΠ°ΡΠ½ΠΎΡΡ‚ΡŒ Π½ΠΎΠ²ΠΎΠ³ΠΎ Ρ‚Ρ€Π΅Ρ…ΠΊΠΎΠΌΠΏΠΎΠ½Π΅Π½Ρ‚Π½ΠΎΠ³ΠΎ Ρ€Π΅ΠΆΠΈΠΌΠ° ΠΈΡ€ΠΈΠ½ΠΎΡ‚Π΅ΠΊΠ°Π½ + оксалиплатин + Ρ„Ρ‚ΠΎΡ€Π°Ρ„ΡƒΡ€. Π’ 1-ΠΉ Π³Ρ€ΡƒΠΏΠΏΠ΅ ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ² (n = 6) Π±Ρ‹Π» ΠΏΡ€ΠΈΠΌΠ΅Π½Π΅Π½ 3-Π½Π΅Π΄Π΅Π»ΡŒΠ½Ρ‹ΠΉ Ρ€Π΅ΠΆΠΈΠΌ Ρ…ΠΈΠΌΠΈΠΎΡ‚Π΅Ρ€Π°ΠΏΠΈΠΈ, Π²ΠΎ 2-ΠΉ Π³Ρ€ΡƒΠΏΠΏΠ΅ (n = 19) – 2-Π½Π΅Π΄Π΅Π»ΡŒΠ½Ρ‹ΠΉ.Π Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚Ρ‹. Π’ настоящСС врСмя ΠΏΠΎΠ»ΡƒΡ‡Π΅Π½Ρ‹ ΠΏΡ€Π΅Π΄Π²Π°Ρ€ΠΈΡ‚Π΅Π»ΡŒΠ½Ρ‹Π΅ Ρ€Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚Ρ‹. ΠœΠ΅Π΄ΠΈΠ°Π½Ρ‹ Π²Ρ€Π΅ΠΌΠ΅Π½ΠΈ Π΄ΠΎ прогрСссирования ΠΈ ΠΎΠ±Ρ‰Π΅ΠΉ выТиваСмости Π½Π΅ достигнуты. Π’ 1-ΠΉ Π³Ρ€ΡƒΠΏΠΏΠ΅ частичная рСгрСссия мСтастазов достигнута Ρƒ 3 (50 %) ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ², Π΄Π»ΠΈΡ‚Π΅Π»ΡŒΠ½Π°Ρ (β‰₯6 мСс) стабилизация Π±ΠΎΠ»Π΅Π·Π½ΠΈ ΠΎΡ‚ΠΌΠ΅Ρ‡Π΅Π½Π° Π΅Ρ‰Π΅ Ρƒ 3 ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ². Π›Π΅Ρ‡Π΅Π±Π½Ρ‹ΠΉ эффСкт (частичная рСмиссия + Π΄Π»ΠΈΡ‚Π΅Π»ΡŒΠ½Π°Ρ стабилизация) ΠΎΡ‚ΠΌΠ΅Ρ‡Π΅Π½ Ρƒ всСх ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ². ВрСмя Π±Π΅Π· прогрСссирования составляло ΠΎΡ‚ 6 Π΄ΠΎ 20 мСс. Π’ΠΎ 2-ΠΉ Π³Ρ€ΡƒΠΏΠΏΠ΅ эффСкт ΠΎΡ†Π΅Π½Π΅Π½ Ρƒ 18 ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ², ΠΏΠΎΠ»ΡƒΡ‡ΠΈΠ²ΡˆΠΈΡ… ΠΊΠ°ΠΊ ΠΌΠΈΠ½ΠΈΠΌΡƒΠΌ 2 курса Ρ…ΠΈΠΌΠΈΠΎΡ‚Π΅Ρ€Π°ΠΏΠΈΠΈ. Π£ 8 ΠΈΠ· 18 ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ² ΠΎΡ‚ΠΌΠ΅Ρ‡Π΅Π½ частичный ΠΎΡ‚Π²Π΅Ρ‚ (ΠΈΠ· Π½ΠΈΡ… 2 ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚Π° Π±Ρ‹Π»ΠΈ Ρ€Π°Π΄ΠΈΠΊΠ°Π»ΡŒΠ½ΠΎ ΠΏΡ€ΠΎΠΎΠΏΠ΅Ρ€ΠΈΡ€ΠΎΠ²Π°Π½Ρ‹), Ρƒ 8 наблюдалась стабилизация Π±ΠΎΠ»Π΅Π·Π½ΠΈ. Π’Π°ΠΊΠΈΠΌ ΠΎΠ±Ρ€Π°Π·ΠΎΠΌ, Π²ΠΎ 2-ΠΉ Π³Ρ€ΡƒΠΏΠΏΠ΅ ΠΎΡ‚Π²Π΅Ρ‚ Π½Π° Π»Π΅Ρ‡Π΅Π½ΠΈΠ΅ достигнут Ρƒ 88,8 % ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ². Π‘ΡƒΠΌΠΌΠ°Ρ€Π½Ρ‹ΠΉ ΠΎΡ‚Π²Π΅Ρ‚ Π½Π° Π»Π΅Ρ‡Π΅Π½ΠΈΠ΅ Π² ΠΎΠ±Π΅ΠΈΡ… Π³Ρ€ΡƒΠΏΠΏΠ°Ρ… составил 91 %.Π’Ρ‹Π²ΠΎΠ΄Ρ‹. ΠŸΡ€Π΅Π΄Π²Π°Ρ€ΠΈΡ‚Π΅Π»ΡŒΠ½Ρ‹Π΅ Π΄Π°Π½Π½Ρ‹Π΅ ΠΌΠΎΠ³ΡƒΡ‚ ΡΠ²ΠΈΠ΄Π΅Ρ‚Π΅Π»ΡŒΡΡ‚Π²ΠΎΠ²Π°Ρ‚ΡŒ ΠΎ Ρ‚ΠΎΠΌ, Ρ‡Ρ‚ΠΎ комбинация оксалиплатина, ΠΈΡ€ΠΈΠ½ΠΎΡ‚Π΅ΠΊΠ°Π½Π° ΠΈ Ρ„Ρ‚ΠΎΡ€Π°Ρ„ΡƒΡ€Π° являСтся эффСктивной, ΠΈΠΌΠ΅Π΅Ρ‚ ΠΏΡ€ΠΈΠ΅ΠΌΠ»Π΅ΠΌΡ‹ΠΉ ΠΏΡ€ΠΎΡ„ΠΈΠ»ΡŒ токсичности ΠΈ ΠΌΠΎΠΆΠ΅Ρ‚ Π±Ρ‹Ρ‚ΡŒ использована Ρƒ ослаблСнных ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ²

    FTORAFUR IN COMBINATION WITH OXALIPLATIN AND IRINOTECAN IN PATIENTS WITH DISSEMINATED COLORECTAL CANCER: PRELIMINARY RESULTS

    No full text
    Objective: to develop an effective, well-tolerated, convenient for outpatient care (without installing a subclavian catheter) three-component treatment regimen that includes ftorafur – an original oral fluoropyrimidine drug.Materials and methods. The study included 25 patients with disseminated colorectal cancer that have never received specific pharmacotherapy. We evaluated the efficacy and safety of a new first-line three-component treatment regimen with oxaliplatin + irinotecan + ftorafur. Patients in group 1 (n = 6) received this regimen for 3 weeks, whereas patients in group 2 (n = 19) received it for 2 weeks.Results. Only preliminary results of the study are currently available. Median time to progression and overall survival are not yet estimated. Three (50 %) patients from group 1 achieved partial regression of metastases; 3 patients from this group had long-term (β‰₯6 months) disease stabilization. Therapeutic effect (partial remission + long-term stabilization) was observed in all patients. Time without progression varied between 6 and 20 months. In group 2, therapeutic effect was estimated in 18 patients that received at least 2 courses of chemotherapy. Eight out of these 18 patients had partial response (2 of them underwent radical surgery); 8 patients had disease stabilization. Thus, 88.8 % of patients from group 2 responded to treatment. In the whole study population (both groups), response to treatment was achieved in 91 % of patients.Conclusion. Our preliminary results suggest that the combination of oxaliplatin, irinotecan and ftorafur is safe and has an acceptable toxicity profile; therefore, it can be used in weakened patients

    SAFETY AND IMMUNOGENICITY OF A NATIONAL COMBINED VACCINE AGAINST PERTUSSIS, DIPHTHERIA, TETANUS, HEPATITIS B AND Hib-INFECTION, CONTAINING ACELLULAR PERTUSSIS COMPONENT, DURING IMMUNIZATION OF ADULTS

    Get PDF
    Aim. Study safety, reactogenicity and immunologic effectiveness of a national combined vaccine against diphtheria, pertussis (acellular component), tetanus, hepatitis B and Hib-infection during immunization of volunteers aged 18 - 60 years. Materials and methods. The study was carried out in accordance with ethical standards and requirements, regulated by Helsinki declaration and Good clinical practice (ICHGCP). In a simple non-randomized clinical trial 20 adult volunteers took part, the mean age of those was 46.9 years. Results. Registered post-vaccination reactions (both local and systemic) were mild and of moderate degree of severity, stopped independently after 2 - 3 days without administration of drug treatment. Postvaccinal complications were not noted. Parameters of general and biochemical analysis of blood, urine, IgE content in dynamics of immunization were within normal limits. A single administration of aAPDT-HepB+Hib to individuals aged 18 - 60 years resulted in development of antibodies against all the components of the preparation. Seroconversion factor fluctuated from 6.9 to 53.5. Conclusion. The results obtained allow to recommend the vaccine for evaluation of its safety, reactogenicity, immunologic and prophylaxis effectiveness in randomized clinical observation trials in children

    National Projects and Improvement of Monitoring of their Implementation in the Sphere of Lifelong Vocational Training

    Get PDF
    This is a concept article proposing trends and methods to improve monitoring of national projects in terms of training personnel for professional development programs at all levels. The paper is based on analysing Russian and international methodologies and practices of education development monitoring. The problem of precise defining personnel development quantitative indicators within national projects implementation is significant both for universities as a part of management decision planning and for government structures, with an information database (correctly representing the process and results of implementing national projects) to be relied upon by the latter. The analysis of Russian federal statistic monitoring forms of personnel development has revealed a number of weaknesses which complicate regular monitoring of national projects implementation. The research has also shown examples of incorrect key indicators setting. The article mainly aims at proposing directions for personnel development methods in ongoing professional development education system according to national project purposes in this part. The article compares EU’s, OECD’s, USA’s, and Russian methodologies and basic monitoring techniques for personnel development. There are revealed their significant differences, advantages and disadvantages, including those used within cross-country comparisons. The analysis shows that foreign models of projects framework cannot be applied to operational monitoring of national projects implementation. The Russian system of federal statistical monitoring requires a certain modification, which can be implemented quite easily and can provide monitoring of national projects implementation in terms of professional development. The article proposes suggestions on improving the monitoring system of national projects implementation according to monitoring purposes. Besides, it can be a basis for future harmonization research for Russian and foreign methodologies of education monitoring. Universities may use the suggestions expressed in the paper for improving national projects implementation monitoring as a part of their management practice. It will allow them to estimate a status and efficiency of their contribution to national projects implementation. The newly proposed methods of national projects realization monitoring can be used by educational bodies and universities within personnel training and improving the system of lifelong vocational training. These methods may be of help when developing control national projects implementation monitoring and vocational training system monitoring in general or in its parts.Π’ настоящСй ΠΊΠΎΠ½Ρ†Π΅ΠΏΡ‚ΡƒΠ°Π»ΡŒΠ½ΠΎΠΉ ΡΡ‚Π°Ρ‚ΡŒΠ΅ Π½Π° основС Π°Π½Π°Π»ΠΈΠ·Π° отСчСствСнной ΠΈ Π·Π°Ρ€ΡƒΠ±Π΅ΠΆΠ½Ρ‹Ρ… ΠΌΠ΅Ρ‚ΠΎΠ΄ΠΎΠ»ΠΎΠ³ΠΈΠΉ ΠΌΠΎΠ½ΠΈΡ‚ΠΎΡ€ΠΈΠ½Π³Π° развития образования ΠΈ ΠΏΡ€Π°ΠΊΡ‚ΠΈΠΊΠΈ ΠΈΡ… примСнСния ΠΏΡ€Π΅Π΄Π»Π°Π³Π°ΡŽΡ‚ΡΡ направлСния ΠΈ ΠΌΠ΅Ρ‚ΠΎΠ΄Ρ‹ ΡΠΎΠ²Π΅Ρ€ΡˆΠ΅Π½ΡΡ‚Π²ΠΎΠ²Π°Π½ΠΈΡ ΠΌΠΎΠ½ΠΈΡ‚ΠΎΡ€ΠΈΠ½Π³Π° Ρ€Π΅Π°Π»ΠΈΠ·Π°Ρ†ΠΈΠΈ Π½Π°Ρ†ΠΈΠΎΠ½Π°Π»ΡŒΠ½Ρ‹Ρ… ΠΏΡ€ΠΎΠ΅ΠΊΡ‚ΠΎΠ² Π² части ΠΏΠΎΠ΄Π³ΠΎΡ‚ΠΎΠ²ΠΊΠΈ ΠΊΠ°Π΄Ρ€ΠΎΠ² ΠΏΠΎ ΠΏΡ€ΠΎΡ„Π΅ΡΡΠΈΠΎΠ½Π°Π»ΡŒΠ½Ρ‹ΠΌ ΠΎΠ±Ρ€Π°Π·ΠΎΠ²Π°Ρ‚Π΅Π»ΡŒΠ½Ρ‹ΠΌ ΠΏΡ€ΠΎΠ³Ρ€Π°ΠΌΠΌΠ°ΠΌ всСх ΡƒΡ€ΠΎΠ²Π½Π΅ΠΉ. ΠŸΡ€ΠΎΠ±Π»Π΅ΠΌΠ° ΠΊΠΎΡ€Ρ€Π΅ΠΊΡ‚Π½ΠΎΠ³ΠΎ опрСдСлСния количСствСнных ΠΏΠΎΠΊΠ°Π·Π°Ρ‚Π΅Π»Π΅ΠΉ ΠΏΠΎΠ΄Π³ΠΎΡ‚ΠΎΠ²ΠΊΠΈ ΠΊΠ°Π΄Ρ€ΠΎΠ² Π² процСссС Ρ€Π΅Π°Π»ΠΈΠ·Π°Ρ†ΠΈΠΈ Π½Π°Ρ†ΠΈΠΎΠ½Π°Π»ΡŒΠ½Ρ‹Ρ… ΠΏΡ€ΠΎΠ΅ΠΊΡ‚ΠΎΠ² Π°ΠΊΡ‚ΡƒΠ°Π»ΡŒΠ½Π° ΠΊΠ°ΠΊ для Π²ΡƒΠ·ΠΎΠ² ΠΏΡ€ΠΈ Π²Ρ‹Ρ€Π°Π±ΠΎΡ‚ΠΊΠ΅ управлСнчСских Ρ€Π΅ΡˆΠ΅Π½ΠΈΠΉ ΠΏΠΎ стратСгии ΠΈΡ… развития Π² сопоставлСнии с Π½Π°Ρ†ΠΈΠΎΠ½Π°Π»ΡŒΠ½Ρ‹ΠΌΠΈ цСлями ΠΈ стратСгичСскими Π·Π°Π΄Π°Ρ‡Π°ΠΌΠΈ развития страны, Ρ‚Π°ΠΊ ΠΈ для ΠΎΡ€Π³Π°Π½ΠΎΠ² государствСнного управлСния. ПослСдниС ΠΏΡ€ΠΈ ΠΏΠΎΠ΄Π³ΠΎΡ‚ΠΎΠ²ΠΊΠ΅ Ρ€Π΅ΡˆΠ΅Π½ΠΈΠΉ Π΄ΠΎΠ»ΠΆΠ½Ρ‹ ΠΎΠΏΠΈΡ€Π°Ρ‚ΡŒΡΡ Π½Π° ΠΈΠ½Ρ„ΠΎΡ€ΠΌΠ°Ρ†ΠΈΠΎΠ½Π½ΡƒΡŽ Π±Π°Π·Ρƒ, ΠΊΠΎΡ€Ρ€Π΅ΠΊΡ‚Π½ΠΎ ΠΎΡ‚ΠΎΠ±Ρ€Π°ΠΆΠ°ΡŽΡ‰ΡƒΡŽ Ρ…ΠΎΠ΄ ΠΈ Ρ€Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚Ρ‹ Ρ€Π΅Π°Π»ΠΈΠ·Π°Ρ†ΠΈΠΈ Π½Π°Ρ†ΠΈΠΎΠ½Π°Π»ΡŒΠ½Ρ‹Ρ… ΠΏΡ€ΠΎΠ΅ΠΊΡ‚ΠΎΠ². Анализ ΠΈΡΠΏΠΎΠ»ΡŒΠ·ΡƒΠ΅ΠΌΡ‹Ρ… Π² России Ρ„ΠΎΡ€ΠΌ Ρ„Π΅Π΄Π΅Ρ€Π°Π»ΡŒΠ½ΠΎΠ³ΠΎ статистичСского наблюдСния ΠΏΠΎΠ΄Π³ΠΎΡ‚ΠΎΠ²ΠΊΠΈ ΠΊΠ°Π΄Ρ€ΠΎΠ² ΠΏΠΎΠ·Π²ΠΎΠ»ΠΈΠ» ΠΎΠ±Π½Π°Ρ€ΡƒΠΆΠΈΡ‚ΡŒ ряд нСдостатков, Π·Π°Ρ‚Ρ€ΡƒΠ΄Π½ΡΡŽΡ‰ΠΈΡ… систСматичСский ΠΌΠΎΠ½ΠΈΡ‚ΠΎΡ€ΠΈΠ½Π³ Ρ€Π΅Π°Π»ΠΈΠ·Π°Ρ†ΠΈΠΈ Π½Π°Ρ†ΠΈΠΎΠ½Π°Π»ΡŒΠ½Ρ‹Ρ… ΠΏΡ€ΠΎΠ΅ΠΊΡ‚ΠΎΠ², Ρ‚Π°ΠΊΠΆΠ΅ Π² процСссС исслСдования Π±Ρ‹Π»ΠΈ выявлСны ΠΏΡ€ΠΈΠΌΠ΅Ρ€Ρ‹ Π½Π΅ΠΊΠΎΡ€Ρ€Π΅ΠΊΡ‚Π½ΠΎΠ³ΠΎ задания Ρ†Π΅Π»Π΅Π²Ρ‹Ρ… ΠΏΠΎΠΊΠ°Π·Π°Ρ‚Π΅Π»Π΅ΠΉ ΠΏΠΎΠ΄Π³ΠΎΡ‚ΠΎΠ²ΠΊΠΈ ΠΊΠ°Π΄Ρ€ΠΎΠ² Π² Π½Π°Ρ†ΠΈΠΎΠ½Π°Π»ΡŒΠ½Ρ‹Ρ… ΠΏΡ€ΠΎΠ΅ΠΊΡ‚Π°Ρ…. ИмСнно это послуТило ΠΏΡ€ΠΈΡ‡ΠΈΠ½ΠΎΠΉ написания Π΄Π°Π½Π½ΠΎΠΉ ΡΡ‚Π°Ρ‚ΡŒΠΈ, Ρ†Π΅Π»ΡŒ ΠΊΠΎΡ‚ΠΎΡ€ΠΎΠΉ – ΠΏΡ€Π΅Π΄Π»ΠΎΠΆΠΈΡ‚ΡŒ направлСния развития ΠΌΠ΅Ρ‚ΠΎΠ΄ΠΈΠΊ ΠΌΠΎΠ½ΠΈΡ‚ΠΎΡ€ΠΈΠ½Π³Π° ΠΏΠΎΠ΄Π³ΠΎΡ‚ΠΎΠ²ΠΊΠΈ ΠΊΠ°Π΄Ρ€ΠΎΠ² Π² систСмС Π½Π΅ΠΏΡ€Π΅Ρ€Ρ‹Π²Π½ΠΎΠ³ΠΎ ΠΏΡ€ΠΎΡ„Π΅ΡΡΠΈΠΎΠ½Π°Π»ΡŒΠ½ΠΎΠ³ΠΎ образования ΠΈ Ρ€Π΅Π°Π»ΠΈΠ·Π°Ρ†ΠΈΠΈ Π½Π°Ρ†ΠΈΠΎΠ½Π°Π»ΡŒΠ½Ρ‹Ρ… ΠΏΡ€ΠΎΠ΅ΠΊΡ‚ΠΎΠ² Π² этой части. Π’ ΡΡ‚Π°Ρ‚ΡŒΠ΅ Ρ€Π°ΡΡΠΌΠ°Ρ‚Ρ€ΠΈΠ²Π°ΡŽΡ‚ΡΡ ΠΈ ΡΠΎΠΏΠΎΡΡ‚Π°Π²Π»ΡΡŽΡ‚ΡΡ мСтодология ΠΈ основныС ΠΌΠ΅Ρ‚ΠΎΠ΄ΠΈΠΊΠΈ ΠΌΠΎΠ½ΠΈΡ‚ΠΎΡ€ΠΈΠ½Π³Π° ΠΏΠΎΠ΄Π³ΠΎΡ‚ΠΎΠ²ΠΊΠΈ ΠΊΠ°Π΄Ρ€ΠΎΠ², примСняСмыС Π² Π•Π‘, ОЭБР, БША, России, Π²Ρ‹ΡΠ²Π»ΡΡŽΡ‚ΡΡ ΠΈΡ… основныС различия, прСимущСства ΠΈ нСдостатки, Π² Ρ‚ΠΎΠΌ числС ΠΏΡ€ΠΈ использовании Π² мСТстрановых сравнСниях. ΠŸΡ€ΠΎΠ²Π΅Π΄Π΅Π½Π½Ρ‹ΠΉ Π°Π½Π°Π»ΠΈΠ· ΠΏΠΎΠΊΠ°Π·Π°Π», Ρ‡Ρ‚ΠΎ для Ρ†Π΅Π»Π΅ΠΉ ΠΌΠΎΠ½ΠΈΡ‚ΠΎΡ€ΠΈΠ½Π³Π° Ρ€Π΅Π°Π»ΠΈΠ·Π°Ρ†ΠΈΠΈ Π½Π°Ρ†ΠΈΠΎΠ½Π°Π»ΡŒΠ½Ρ‹Ρ… ΠΏΡ€ΠΎΠ΅ΠΊΡ‚ΠΎΠ² Π·Π°Ρ€ΡƒΠ±Π΅ΠΆΠ½Ρ‹Π΅ ΠΌΠ΅Ρ‚ΠΎΠ΄ΠΈΠΊΠΈ Π² силу мСтодологичСских особСнностСй Π½Π΅ ΠΌΠΎΠ³ΡƒΡ‚ ΠΈΡΠΏΠΎΠ»ΡŒΠ·ΠΎΠ²Π°Ρ‚ΡŒΡΡ для ΠΎΠΏΠ΅Ρ€Π°Ρ‚ΠΈΠ²Π½ΠΎΠ³ΠΎ ΠΌΠΎΠ½ΠΈΡ‚ΠΎΡ€ΠΈΠ½Π³Π°, Π° российская систСма Ρ„Π΅Π΄Π΅Ρ€Π°Π»ΡŒΠ½ΠΎΠ³ΠΎ статистичСского наблюдСния Ρ‚Ρ€Π΅Π±ΡƒΠ΅Ρ‚ ΠΎΠΏΡ€Π΅Π΄Π΅Π»Π΅Π½Π½ΠΎΠΉ ΠΌΠΎΠ΄ΠΈΡ„ΠΈΠΊΠ°Ρ†ΠΈΠΈ, которая достаточно Π»Π΅Π³ΠΊΠΎ Ρ€Π΅Π°Π»ΠΈΠ·ΡƒΠ΅ΠΌΠ° ΠΈ ΠΏΠΎΠ·Π²ΠΎΠ»ΠΈΡ‚ ΠΎΠ±Π΅ΡΠΏΠ΅Ρ‡ΠΈΡ‚ΡŒ ΠΌΠΎΠ½ΠΈΡ‚ΠΎΡ€ΠΈΠ½Π³ Ρ€Π΅Π°Π»ΠΈΠ·Π°Ρ†ΠΈΠΈ Π½Π°Ρ†ΠΈΠΎΠ½Π°Π»ΡŒΠ½Ρ‹Ρ… ΠΏΡ€ΠΎΠ΅ΠΊΡ‚ΠΎΠ² Π² части ΠΏΠΎΠ΄Π³ΠΎΡ‚ΠΎΠ²ΠΊΠΈ ΠΊΠ°Π΄Ρ€ΠΎΠ² с ΠΏΡ€ΠΎΡ„Π΅ΡΡΠΈΠΎΠ½Π°Π»ΡŒΠ½Ρ‹ΠΌ ΠΎΠ±Ρ€Π°Π·ΠΎΠ²Π°Π½ΠΈΠ΅ΠΌ. ΠŸΡ€ΠΈΠ²Π΅Π΄Π΅Π½Π½Ρ‹Π΅ Π² ΡΡ‚Π°Ρ‚ΡŒΠ΅ прСдлоТСния ΠΏΠΎ ΡΠΎΠ²Π΅Ρ€ΡˆΠ΅Π½ΡΡ‚Π²ΠΎΠ²Π°Π½ΠΈΡŽ систСмы ΠΌΠΎΠ½ΠΈΡ‚ΠΎΡ€ΠΈΠ½Π³Π° Ρ€Π΅Π°Π»ΠΈΠ·Π°Ρ†ΠΈΠΈ Π½Π°Ρ†ΠΈΠΎΠ½Π°Π»ΡŒΠ½Ρ‹Ρ… ΠΏΡ€ΠΎΠ΅ΠΊΡ‚ΠΎΠ² ΠΌΠΎΠ³ΡƒΡ‚ Π² ΠΏΠΎΡΠ»Π΅Π΄ΡƒΡŽΡ‰Π΅ΠΌ Π΄Π΅Ρ‚Π°Π»ΠΈΠ·ΠΈΡ€ΠΎΠ²Π°Ρ‚ΡŒΡΡ Π² соотвСтствии с цСлями ΠΌΠΎΠ½ΠΈΡ‚ΠΎΡ€ΠΈΠ½Π³Π°, Π° Ρ‚Π°ΠΊΠΆΠ΅ ΠΏΠΎΡΠ»ΡƒΠΆΠΈΡ‚ΡŒ основой для исслСдований Π² сфСрС Π³Π°Ρ€ΠΌΠΎΠ½ΠΈΠ·Π°Ρ†ΠΈΠΈ российской ΠΈ Π·Π°Ρ€ΡƒΠ±Π΅ΠΆΠ½Ρ‹Ρ… ΠΌΠ΅Ρ‚ΠΎΠ΄ΠΎΠ»ΠΎΠ³ΠΈΠΉ ΠΌΠΎΠ½ΠΈΡ‚ΠΎΡ€ΠΈΠ½Π³Π° образования. Π‘ Ρ‚ΠΎΡ‡ΠΊΠΈ зрСния ΠΏΡ€Π°ΠΊΡ‚ΠΈΠΊΠΈ унивСрситСтского ΠΌΠ΅Π½Π΅Π΄ΠΆΠΌΠ΅Π½Ρ‚Π° ΠΏΡ€Π΅Π΄Π»Π°Π³Π°Π΅ΠΌΡ‹Π΅ направлСния ΡΠΎΠ²Π΅Ρ€ΡˆΠ΅Π½ΡΡ‚Π²ΠΎΠ²Π°Π½ΠΈΡ ΠΌΠΎΠ½ΠΈΡ‚ΠΎΡ€ΠΈΠ½Π³Π° Ρ€Π΅Π°Π»ΠΈΠ·Π°Ρ†ΠΈΠΈ Π½Π°Ρ†ΠΈΠΎΠ½Π°Π»ΡŒΠ½Ρ‹Ρ… ΠΏΡ€ΠΎΠ΅ΠΊΡ‚ΠΎΠ² ΠΌΠΎΠ³ΡƒΡ‚ Π² ΠΈΠ½ΠΈΡ†ΠΈΠ°Ρ‚ΠΈΠ²Π½ΠΎΠΌ порядкС Ρ€Π΅Π°Π»ΠΈΠ·ΠΎΠ²Ρ‹Π²Π°Ρ‚ΡŒΡΡ Π½Π° ΡƒΡ€ΠΎΠ²Π½Π΅ ΠΊΠΎΠ½ΠΊΡ€Π΅Ρ‚Π½Ρ‹Ρ… Π²ΡƒΠ·ΠΎΠ², Ρ‡Ρ‚ΠΎ ΠΏΠΎΠ·Π²ΠΎΠ»ΠΈΡ‚ ΠΈΠΌ ΠΎΡ†Π΅Π½ΠΈΡ‚ΡŒ состояниС ΠΈ Ρ€Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚ΠΈΠ²Π½ΠΎΡΡ‚ΡŒ своСго Π²ΠΊΠ»Π°Π΄Π° Π² Ρ€Π΅Π°Π»ΠΈΠ·Π°Ρ†ΠΈΡŽ Π½Π°Ρ†ΠΈΠΎΠ½Π°Π»ΡŒΠ½Ρ‹Ρ… ΠΏΡ€ΠΎΠ΅ΠΊΡ‚ΠΎΠ². ΠŸΡ€Π΅Π΄Π»ΠΎΠΆΠ΅Π½Π½Ρ‹Π΅ Π² ΡΡ‚Π°Ρ‚ΡŒΠ΅ Π½ΠΎΠ²Ρ‹Π΅ ΠΊΠΎΠ½ΠΊΡ€Π΅Ρ‚Π½Ρ‹Π΅ ΠΌΠ΅Ρ‚ΠΎΠ΄Ρ‹ ΠΎΡ€Π³Π°Π½ΠΈΠ·Π°Ρ†ΠΈΠΈ ΠΌΠΎΠ½ΠΈΡ‚ΠΎΡ€ΠΈΠ½Π³Π° Ρ€Π΅Π°Π»ΠΈΠ·Π°Ρ†ΠΈΠΈ Π½Π°Ρ†ΠΈΠΎΠ½Π°Π»ΡŒΠ½Ρ‹Ρ… ΠΏΡ€ΠΎΠ΅ΠΊΡ‚ΠΎΠ² Π² части ΠΏΠΎΠ΄Π³ΠΎΡ‚ΠΎΠ²ΠΊΠΈ ΠΊΠ°Π΄Ρ€ΠΎΠ² ΠΈ направлСния ΡΠΎΠ²Π΅Ρ€ΡˆΠ΅Π½ΡΡ‚Π²ΠΎΠ²Π°Π½ΠΈΡ ΠΌΠΎΠ½ΠΈΡ‚ΠΎΡ€ΠΈΠ½Π³Π° систСмы Π½Π΅ΠΏΡ€Π΅Ρ€Ρ‹Π²Π½ΠΎΠ³ΠΎ ΠΏΡ€ΠΎΡ„Π΅ΡΡΠΈΠΎΠ½Π°Π»ΡŒΠ½ΠΎΠ³ΠΎ образования ΠΌΠΎΠ³ΡƒΡ‚ ΠΈΡΠΏΠΎΠ»ΡŒΠ·ΠΎΠ²Π°Ρ‚ΡŒΡΡ ΠΎΡ€Π³Π°Π½Π°ΠΌΠΈ управлСния ΠΎΠ±Ρ€Π°Π·ΠΎΠ²Π°Π½ΠΈΠ΅ΠΌ ΠΈ Π²ΡƒΠ·Π°ΠΌΠΈ для ΡΠΎΠ²Π΅Ρ€ΡˆΠ΅Π½ΡΡ‚Π²ΠΎΠ²Π°Π½ΠΈΡ ΠΌΠΎΠ½ΠΈΡ‚ΠΎΡ€ΠΈΠ½Π³Π° Ρ€Π΅Π°Π»ΠΈΠ·Π°Ρ†ΠΈΠΈ Π½Π°Ρ†ΠΈΠΎΠ½Π°Π»ΡŒΠ½Ρ‹Ρ… ΠΏΡ€ΠΎΠ΅ΠΊΡ‚ΠΎΠ² ΠΈ ΠΌΠΎΠ½ΠΈΡ‚ΠΎΡ€ΠΈΠ½Π³Π° систСмы Π½Π΅ΠΏΡ€Π΅Ρ€Ρ‹Π²Π½ΠΎΠ³ΠΎ ΠΏΡ€ΠΎΡ„Π΅ΡΡΠΈΠΎΠ½Π°Π»ΡŒΠ½ΠΎΠ³ΠΎ образования Π² Ρ†Π΅Π»ΠΎΠΌ ΠΈ Π΅Π΅ ΠΎΡ‚Π΄Π΅Π»ΡŒΠ½Ρ‹Ρ… элСмСнтов

    Combination therapy with ruxolitinib plus low-dose cytarabine or mercaptopurine in patients with blast-phase myelofibrosis

    No full text
    Patients with myelofibrosis in blast-phase commonly have a median overall survival of only 3–6 months. Given the older median age of onsetΒ and heavy pretreatment, intensive chemotherapy often is not appropriate and has low efficacy with high toxicity. Ruxolitinib (a JAK1/2 inhibitor)Β has provided significant clinical benefits in patients with chronic phase myelofibrosis. We report our experience of treating blastphaseΒ myelofibrosis patients with the combination therapy of ruxolitinib plus low dose mercaptopurine or low-dose cytarabine. The casesΒ presented here demonstrated the feasibility and tolerability of combination continuous ruxolitinib treatment with mercaptopurine or low-doseΒ cytarabine for patients with blast-phase myelofibrosis. The efficacy of these combination regimens is encouraging
    corecore